Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sapiens Reports 16.7% Year-Over-Year Increase in Quarterly Revenue to $40.4 Million

FORM, FORTY, SPNS

Non-GAAP Quarterly Operating Profit Increased by 22.6% Year-Over-Year; Company Expects Full-Year Revenues to be at the High-End of the Guidance

HOLON, Israel, Nov. 12, 2014 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, with an emerging focus on the broader financial services sector, and a member of the Formula Group (NASDAQ: FORTY and TASE: FORT), announced today its financial results for the third quarter ended September 30, 2014.

Sapiens International Corporation Logo

Third Quarter Highlights:

  • Non-GAAP revenue of $40.4 million, up 16.7% compared to $34.6 million in the third quarter of 2013.
  • Non-GAAP operating profit was $4.4 million compared to $3.6 million in the third quarter of 2013, an increase of 22.6%.
  • Non-GAAP net income attributable to Sapiens' shareholders totaled $4.1 million or $0.08 per diluted share compared to $4.1 million, or $0.10 per share in the third quarter last year. Net income this quarter was same as last year due to one-time tax saving in the third quarter of 2013.
  • Cash, cash equivalents and securities investments as of September 30, 2014 was $78.4 million, with no debt.

Year-to-Date Financial Highlights:

  • Non-GAAP revenue increased by 16.6% to $115.7 million from $99.2 million in the same period of 2013.
  • Non-GAAP operating profit was $12.1 million compared to $10.3 million in the first nine months of 2013, an increase of 17.2%.
  • Non-GAAP net income attributable to Sapiens' shareholders reached $11.1 million, compared to $10.3 million in the year ago period, an increase of 7.8%.

Roni Al-Dor, President and CEO of Sapiens, commented: "Sapiens continues to deliver strong revenue growth, improved profitability, and cash flow, we remain optimistic about our ability to continue our growth in the near-term and long-term future. The enhancements we completed in our software offerings has broadened our addressable market, in terms of customer lines of business.

"We have been investing in sales and marketing, especially in our key geographies, North America and Europe, and these investments are producing accelerated growth and sustained profitability, bolstering our confidence for 2015. Our pipeline of opportunities continues to expand, and we now believe our revenue will come in at the high end of our guidance of $154 to $158 million for the full-year, and we look forward to building on this success in the coming year."

Quarterly Results Conference Call

Sapiens management will host its earnings conference call today, November 12th, 2014 at 9:00 am EST, 4:00 pm Israel, to discuss the results. To participate in the call, please dial in to the following numbers: United States + 1.866.860.9642; International: +972.3. 918.0650; UK: 0.800.051.8913.

The live webcast of the call will also be accessible on Sapiens Website at: http://www.sapiens.com/webcasts-presentations.htm

An online replay will also be available approximately two hours following the call, the replay will be accessible until November 19th, 2014, and may be accessed by dialing:
United States: +1.888.269.0005; International: +972.3.925.5928

A recorded version of the webcast will also be available via the Company website, for three months at the same location.

Non-GAAP Financial Measures

This press release contains the following non-GAAP financial measures: Non-GAAP revenue, Non-GAAP gross profit, Non-GAAP operating income, Non-GAAP net income attributed to Sapiens shareholders, Non-GAAP basic and diluted earnings per share.

Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens' financial condition and results of operations. The Company's management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company's board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing the Company's financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

Management of the Company does not consider these non-GAAP measures in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures. In order to compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company's business.

Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.

The Company defines Adjusted EBITDA as net Profit, adjusted for stock-based compensation expense, depreciation and amortization, capitalized internal-use software development costs, Amortization of internal-use software development costs interest expense, provision for income taxes and other income (expenses). These amounts are often excluded by other companies to help investors understand the operational performance of their business. The Company uses Adjusted EBITDA as a measurement of its operating performance because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflect an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures provide a more complete understanding of factors and trends affecting its business.

About Sapiens

Sapiens International Corporation (NASDAQ and TASE: SPNS) is a leading global provider of software solutions for the insurance industry, with an emerging focus on the broader financial services sector. We offer core, end-to-end solutions to the global general insurance, property and casualty, life, pension and annuities, and retirement markets, as well as business decision management software. We have a track record of over 30 years in delivering superior software solutions to more than 130 financial services organizations. Our team of about 1,000 professionals operates through our fully-owned subsidiaries in North America, the United Kingdom, EMEA and Asia Pacific. For more information: www.sapiens.com.

Forward Looking Statement

Some of the statements in this press release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities and Exchange Act of 1934 and the United States Private Securities Litigation Reform Act of 1995. Words such as "will," "expects," "believes" and similar expressions are used to identify these forward-looking statements (although not all forward-looking statements include such words). These forward-looking statements, which may include, without limitation, projections regarding our future performance and financial condition, are made on the basis of management's current views and assumptions with respect to future events. Any forward-looking statement is not a guarantee of future performance and actual results could differ materially from those contained in the forward-looking statement. These statements speak only as of the date they were made, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. We operate in a changing environment. New risks emerge from time to time and it is not possible for us to predict all risks that may affect us. For more information regarding these risks and uncertainties as well as certain additional risks that we face, you should refer to the Risk Factors detailed in Item 3 of Part III of our Annual Report on Form 20-F for the year ended December 31, 2013 and subsequent reports and registration statements filed from time to time with the Securities and Exchange Commission.

Investors and Media Contact:
Yaffa Cohen-Ifrah

Vice President Corporate Marketing and Communications
Sapiens International
US Mobile: +1 201-250-9414
Mobile: +972 54-9099039
Email: yaffa.cohen-ifrah@sapiens.com

 

 

Summary of Non-GAAP financial Information
U.S. dollars in thousands (except per share amounts)








 Three months ended


 Nine months ended



 September 30,


 September 30,



2014


2013


2014


2013



(unaudited)


(unaudited)


(unaudited)


(unaudited)










 Revenues


40,398


34,613


115,677


99,185

 Gross profit


16,392


13,868


46,715


40,936

 Operating profit


4,403


3,592


12,056


10,291

 Net income attributable to Sapiens' shareholders 

4,084


4,076


11,060


10,259

Adjusted EBITDA

4,796


3,848


13,233


11,081

 Basic earnings per share

0.09


0.10


0.24


0.26

 Diluted earnings per share

0.08


0.10


0.23


0.25

 

 

Revenues by category
U.S. dollars in thousands






Three months ended
September 30, 2014


Nine months ended
 September 30, 2014


Revenues

Percentage


Revenues

Percentage



License

2,875

7.1%


10,765

9.3%

Services and Maintenance

37,523

92.9%


104,912

90.7%

Total

40,398

100.0%


115,677

100.0%

 

 

 Revenues by geographic breakdown
U.S. dollars in thousands






Three months ended

September 30, 2014


Nine months ended

 September 30, 2014


Revenues

Percentage


Revenues

Percentage



North America

13,404

33.2%


36,025

31.1%

Europe

22,247

55.1%


69,014

59.7%

APAC

4,747

11.7%


10,638

9.2%

Total

40,398

100%


115,677

100%

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

U.S. dollars in thousands (except per share amounts)










  Three months ended


  Nine months ended




 September 30,


 September 30,




2014


2013


2014


2013




 (unaudited)


 (unaudited)


 (unaudited)


 (unaudited)











 Revenue


40,398


34,613


115,677


99,185

 Cost of revenue


25,460


22,076


73,364


62,279











 Gross profit


14,938


12,537


42,313


36,906











 Operating Expenses:










 Research and development, net


2,856


2,900


8,600


9,078


 Selling, marketing, general and administrative


8,283


6,521


23,357


19,270

 Total operating expenses


11,139


9,421


31,957


28,348











 Operating income


3,799


3,116


10,356


8,558











 Financial income, net


(93)


(2)


(150)


(308)

 Taxes and other expenses, net


80


227


542


654





















 Net income


3,812


2,891


9,964


8,212











 Attributable to non-controlling interest


100


18


125


29











 Net income attributable to Sapiens' shareholders


3,712


2,873


9,839


8,183





















 Basic earnings per share


0.08


0.07


0.21


0.21











 Diluted earnings per share


0.08


0.07


0.20


0.20











 Weighted average number of shares









 outstanding used to compute:



















 Basic earnings per share


47,607


39,302


46,841


39,043

 Diluted earnings per share


49,006


41,729


48,235


41,297

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES

RECONCILIATION OF GAAP TO NON-GAAP RESULTS

U.S. dollars in thousands (except per share amounts)








  Three months ended


 Nine months ended



 September 30,


 September 30,



2014


2013


2014


2013

 Non-GAAP revenue


40,398


34,613


115,677


99,185



















 GAAP gross profit


14,938


12,537


42,313


36,906

 Amortization of capitalized software


1,226


1,108


3,732


3,370

 Amortization of other intangible assets


228


223


670


660

 Non-GAAP gross profit


16,392


13,868


46,715


40,936



















 GAAP operating income


3,799


3,116


10,356


8,558

 Gross profit adjustments


1,454


1,331


4,402


4,030

 Capitalization of software development


(1,451)


(1,398)


(4,538)


(3,936)

 Amortization of other intangible assets


319


298


995


940

 Stock-based compensation


282


245


841


699

 Non-GAAP operating income


4,403


3,592


12,056


10,291



















 GAAP net income attributable to Sapiens' shareholders


3,712


2,873


9,839


8,183

 Operating income adjustments


604


476


1,700


1,733

 Other


(232)


727


(479)


343

 Non-GAAP net income attributable to Sapiens' shareholders


4,084


4,076


11,060


10,259




























 Non-GAAP basic earnings per share 


0.09


0.10


0.24


0.26










 Non-GAAP diluted earnings per share


0.08


0.10


0.23


0.25



















 Shares used in computing US NON GAAP basic earnings per share (in thousands)


47,607


39,302


46,841


39,043

 Shares used in computing US NON GAAP diluted earnings per share (in thousands)


49,006


41,729


48,235


41,297

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

U.S. Dollars in thousands










September 30,


December 31,




2014


2013




 (unaudited)


 (unaudited)







 ASSETS











 CURRENT ASSETS:






Cash and cash equivalents


45,125


70,313


Trade receivables, net


26,401


23,669


 Other receivables and prepaid expenses


4,101


4,126


 Deferred Taxes


1,863


2,420








 Total current assets


77,490


100,528







 LONG-TERM ASSETS:






Marketable Securities


33,272


-


Property and equipment, net


5,269


5,263


Severance pay fund


10,917


11,228


Other intangible assets, net


28,669


30,014


Other long-term assets


3,098


2,957


Goodwill


69,999


72,438








 Total long-term assets


151,224


121,900







 TOTAL ASSETS


228,714


222,428








 LIABILITIES AND EQUITY











 CURRENT LIABILITIES:






 Trade payables


4,878


6,517


 Accrued expenses and other liabilities


23,824


21,248


Deferred revenue


10,009


9,928








 Total current liabilities


38,711


37,693







 LONG-TERM LIABILITIES:






 Other long-term liabilities


1,175


1,712


 Accrued severance pay


12,324


12,615








 Total long-term liabilities


13,499


14,327







 EQUITY



176,504


170,408







 TOTAL LIABILITIES AND EQUITY


228,714


222,428

 

 

SAPIENS INTERNATIONAL CORPORATION

CONSOLIDATED STATEMENT OF CASH FLOW

U.S. Dollars in thousands




For the Nine months ended


30/09/2014

30/09/2013


(unaudited)

(unaudited)

Cash flows from operating activities:



Net profit

9,964

8,212

Adjustments to reconcile net loss to net cash provided by operating activities:



Depreciation

1,177

790

Amortization

5,397

4,970

Amortization of premium and accrued interest on marketable securities

(126)

-

Stock-based compensation related to options issued employees

841

699

Increase in trade receivables

(3,503)

(8,427)

Deferred tax assets

54

614

Increase in other operating assets

(492)

(1,044)

Increase (Decrease)  in trade payables

(1,470)

2,986

Increase (Decrease) in Other operating liabilities

3,799

(465)

Increase  in Deferred revenues

435

1,073

Severance pay

110

198




Net cash provided by operating activities

16,186

9,606




Cash flows from investing activities:



Purchase of property and equipment

(1,377)

(2,782)

Purchase of marketable securities

(34,623)

-

Proceeds from sales of marketable securities

1,014

-

Payments for business acquisition, net of cash acquired

(2,064)

-

Increase in capitalized software development costs

(4,538)

(3,938)

Decrease in Restricted Cash

538

225

Net cash used in investing activities

(41,050)

(6,495)




Cash flows from financing activities:



Distribution of dividend

-

(5,795)

Proceeds from employee stock options exercised

1,508

1,574

Net cash provided by (used in) financing activities

1,508

(4,221)




Effect of exchange rate changes on cash and cash equivalents

(1,832)

171




Decrease in cash and cash equivalents

(25,188)

(939)

Cash and cash equivalents at the beginning of period

70,313

29,050




Cash and cash equivalents at the end of period

45,125

28,111

 

Logo - http://photos.prnewswire.com/prnh/20120508/531104

SOURCE Sapiens International Corporation



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today